Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Showing 20 of 0 results

Not applicableStudy completedNCT04008927
What this trial is testing

A Community-based Intervention Among Active Drug Users in Montpellier

Who this might be right for
Drug UseHCV Infection
ANRS, Emerging Infectious Diseases 554
Not applicableUnknownNCT03420573
What this trial is testing

Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection

Who this might be right for
Parkinson Disease
Kasr El Aini Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00423670
What this trial is testing

Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 765
Early research (Phase 1)WithdrawnNCT00947245
What this trial is testing

Japanese Bridging Study Conducted in the United States

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb
Not applicableUnknownNCT02657694
What this trial is testing

Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods

Who this might be right for
Hepatitis C
FixHepC 10,000
Testing effectiveness (Phase 2)WithdrawnNCT00930995
What this trial is testing

Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Kaiser Permanente
Large-scale testing (Phase 3)UnknownNCT03540212
What this trial is testing

Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus

Who this might be right for
Chronic HCV Infection
Ain Shams University 50
Large-scale testing (Phase 3)Study completedNCT02023112
What this trial is testing

Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus
AbbVie 171
Testing effectiveness (Phase 2)Study completedNCT00851890
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
AbbVie (prior sponsor, Abbott) 30
Not applicableStudy completedNCT01159613
What this trial is testing

Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

Who this might be right for
Chronic Hepatitis C Viral Infection
Ziv Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01132313
What this trial is testing

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 488
Large-scale testing (Phase 3)Study completedNCT00624325
What this trial is testing

Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 30
Not applicableStudy completedNCT03362476
What this trial is testing

Computer-based Intervention for Alcohol-using HIV/HCV+ Women

Who this might be right for
Human Immunodeficiency VirusHepatitis CAlcohol Abuse
New York University 200
Not applicableStudy completedNCT02782247
What this trial is testing

Dynamic Liver Tests in Liver Disease

Who this might be right for
Hepatitis BHepatitis C
Queen Mary University of London 52
Testing effectiveness (Phase 2)UnknownNCT03261349
What this trial is testing

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Who this might be right for
Indolent Lymphoma
National Taiwan University Hospital 21
Not applicableStudy completedNCT05710120
What this trial is testing

Hepatitis C Screening Alerts

Who this might be right for
Hepatitis C
Epividian 125,706
Early research (Phase 1)Study completedNCT00971308
What this trial is testing

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 37
Not applicableStudy completedNCT00209118
What this trial is testing

Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C

Who this might be right for
Hepatitis CDepressionInterferon-alpha Associated Side Effects
Emory University 60
Early research (Phase 1)Study completedNCT01181024
What this trial is testing

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 82
Not applicableStudy completedNCT03290755
What this trial is testing

Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux

Who this might be right for
Human Immunodeficiency Virus (HIV)Hepatitis c
University Hospital, Bordeaux 29
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation